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Carla DeMuro-Mercon, MS21GlaxoSmithKline, Durham, NC, USA; 2RTI Health Solutions, Research Triangle Park, NC, USAA B S T R A C TObjectives: The goal of this study was to provide recommended steps
to assess measurement comparability using a crossover study design
and to demonstrate these steps using a short patient-reported outcome
(PRO) instrument as an example. Methods: The example PRO instru-
ment was administered via paper,Web, interactive voice response sys-
tem, and interview; a randomized crossover design was used to gather
data across the multiple administration types. Participants completed
the PRO instrument, demographic and health questions, and a short
preference questionnaire. Evaluation included comparisons of the
item-level responses and agreement, comparison ofmean scale scores,
score classifications, and questions designed to collect usability and
administration preference. Here the authors provide a four-step eval-
uation guide to evaluate measurement comparability and illustrate
these steps using a case-finding tool. Results: In the example, item-
level kappa statistics between the paper and the alternate versions
ranged from good to excellent, intraclass correlation coefficient for
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doi:10.1016/j.jval.2010.12.007mean scores were above 0.70, and the rate of disagreement ranged
from 2% to 14%. In addition, although participants had an administra-
tion preference, they reported few difficulties with the versions they
were assigned.Conclusions: The steps described in this article provide
a guide for evaluating whether to combine scores across administra-
tion versions to simplify analyses and interpretation under a crossover
design. The guide recommends the investigation of item-level re-
sponses, summary scores, and participant usability/preference when
comparing versions, with each step providing unique information to
support comprehensive evaluation and informed decisions regarding
whether to combine data.
Keywords: alternate versions, comparability, COPD, Lung Function
Questionnaire, patient-reported outcomes, psychometrics, screening.
Copyright © 2011, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
As the importance of patient perspectives in burden of illness
studies and pharmaceutical product assessments increases, so do
the number of evaluations of the quality of patient-reported out-
come (PRO) information. Participant responses to PRO instru-
ments may be influenced by how the information is collected, the
amount of effort it takes to respond to a question, and participant
willingness to respond without bias (depending on the topic). Pro-
viding patients with choices in how their data are collected (e.g.,
electronic vs. paper) may alleviate some of these influences and
lead to greater patient participation; less missing data; improved
data quality; and in some cases, decreased costs in data collection.
However, providing alternate methods for data collection also in-
creases the need to evaluate the data in terms of comparability
acrossmethods if the data, or results from the data, are likely to be
combined [1].
Measures are considered equivalent when they exhibit compa-
rablemeasurement properties. According to American Psycholog-
ical Association guidelines, measurement equivalence can be
demonstrated by establishing that the rank orders of scores of
individuals tested in alternative versions closely approximate
* Address Correspondence to: Theresa Gilligan, RTI Health Solutio
E-mail: gilligan@rti.org.
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.each other, and that the means, dispersions, and shapes of the
score distributions are approximately the same [1,2]. Although not
as stringent as the American Psychological Association’s position
for “equivalence” between different modes, the US Food and Drug
Administration guidance specifically suggests that clinical trial
sponsors ensure the “comparability” of electronic PRO and paper-
based PRO measures via empirically based methods [3]. In re-
sponse to the draft of the Food and Drug Administration PRO guid-
ance, the International Society for Pharmacoeconomics and
Outcomes Research electronic PRO Task Force published explicit
recommendations on the appropriate statisticalmethods for com-
paring modes based on the level of modification (i.e., minor, mod-
erate, or substantial) made to the original PRO [4].
The goal of this study (GlaxoSmithKline No. ADC001HO) was to
rovide a guideline of recommended steps to evaluate measure-
ent comparability and to demonstrate these steps using, as an
xample, the Lung Function Questionnaire (LFQ), a simple case-
nding tool. A randomized crossover design was used to gather
ata across two administration modes (self- and interviewer ad-
inistered) by multiple data collection methods (i.e., paper, Web,
nteractive-voice response system [IVRS], and interviewer). The
valuation included comparisons of the psychometric properties,
040 Cornwallis Road, Research Triangle Park, NC 27709, USA.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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713V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 7 1 2 – 7 2 0scale scores, score classifications, and questions designed to col-
lect usability and administration preference.
Methods
Instruments
The LFQ is a simple five-item self-administered case-finding tool
to screen individuals at greater risk for airflow obstruction who
may benefit from further comprehensive evaluation. The LFQ was
developed as a paper-based tool and validated in a cross-sectional
study at two primary care offices in which screening properties
and scoring were explored [5,6]. As a means of promoting wide-
pread use of the LFQ, three additional versions were developed:
eb-based, interviewer-based, and IVRS-based. The five LFQ
tems were the same across the four versions and asked patients
o think about how they were feeling physically when they expe-
Fig. 1 – Survienced cough with mucus, chest wheezing, whistling or rattling,nd shortness of breath during physical activity, and to report their
ength of smokinghistory andage (see the Survey Instrument, Fig. 1).
ach item included five possible responses, coded from one to five
nd a sum score was computed as the sum of the five items ranging
rom 5 to 25, with lower scores indicating risk of obstruction.
Hanania et al. [5] determined that a total score of 18 was an
ppropriate cut point to indicate a greater risk of airway obstruc-
ion. In their developmental studies, a cut point of 18 allowed for a
ensitivity of 82.6% and a specificity of 47.8%, and correctly classi-
ed 54.3% of patients with known airway obstruction based on the
atio of forced expiratory volume in 1 second to forced vital capac-
ty being less than 0.70 as the gold standard. The cutpoint was set
ith the intention of identifying the majority of patients who
ight have chronic obstructive pulmonary disease.
Additional data collected
In addition to the LFQ, at Visit 1 participants completed a brief,
nstrument.ey Iself-administered background questionnaire to collect demo-
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related medical history, activity limitations, smoking history, and
information about computer knowledge and experience. At Visit 2,
participants’ general health status and presence of active colds or
infections were assessed.
Study design
A cross-sectional primary data collection included participants
who were 40 years of age or older; self-reported current or former
smokers (defined as  10 pack years); able to provide informed
consent; able to read and understand English; and did not have a
diagnosis of chronic obstructive pulmonary disease, emphysema,
or asthma. A two-visit, crossover design was employed in which,
in addition to completing the original paper-based version of the
LFQ, participants were randomly assigned to complete one of
three alternate versions of the LFQ. In addition, patients com-
pleted a satisfaction survey designed to ascertain participants’ ac-
ceptance and preference for the different LFQ administration
types. Participants were assigned to one of six sequence groups
based on the LFQ version completed and order of administration
(i.e., paper–Web, paper–IVRS, paper–interviewer, Web–Paper,
IVRS–paper, and interviewer–paper) at two visits (Fig. 2). A 7-day
indow was chosen between visits to minimize the risk of a
hange in a patient’s health status.
Sample size justification
Crossover designs greatly reduce the sample size required for
evaluating measurement comparability or equivalence because
subjects serve as their own controls, reducing variability [4]. An-
other issue to consider when determining the appropriate power
computation is the ultimate purpose of the instrument. If the pur-
pose of the instrument is to rank order scores to compare individ-
uals or groups (e.g., treatments), then larger sample sizes are nec-
essary to detect minimal mean differences in scores and establish
equivalence [4,7,8]. In fact, small sample sizes virtually guaran-
tee a failure to find significant differences (a zero null); hence,
for equivalence testing of the mean differences, the null hy-
pothesis test must be framed so that it tests whether the mean
difference is greater than a specified difference. If the purpose
of the instrument is to classify individuals into groups, then the
sample size considerations are more appropriately determined
based on the desired precision of statistics such as the intra-
class correlation coefficient (ICC). Because the LFQ was devel-
oped as a case-finding tool for screening patients, the sample
size for this example was based on the ICC. Coons et al. [4]
reported that at least 43 subjects with two assessments would
be required for 80% power to show evidence that the population
ICC is above 0.70 with 95% confidence if the observed ICC is 0.85
using the approximate method used by Walter et al. [7]. Accord-
ng to Bonett’s approximate method [9], approximately 31 sub-
Fig. 2 – Study Design Diagram.ects who are assessed twice would be necessary to estimatehat an ICC of 0.85 is larger than 0.70 with a 95% confidence level
ith a width of 0.2. Our target sample of 50 subjects per paper
nd alternate version pair is adequate based on the Walter and
onett approximate methods.
Subject recruitment
Qualitative research firms in Pennsylvania and North Carolina
identified and recruited appropriate study participantswith a self-
reported smoking history from their records. The qualitative sites
prescreened potential participants by telephone, and eligible sub-
jects who gave written consent to participate completed the LFQ
and additional demographic and medical history information.
Each site recruited approximately 75 subjects for a target enroll-
ment of 150 participants. Each participant was asked to complete
two study visits. The studywas approved by a central institutional
review board.
Criteria for inclusion in comparison evaluation
Participants included in the analysis were those who completed two
LFQ administrations and all LFQ questions at both visits. In addition,
participantswerescreenedforactivecoldsorinfectionsateachvisitand
omitted from themainanalysis if their status differedbetweenvisits to
mitigate bias caused by acute illnesses rather than a change (or no
change) in response due to administration version.
LFQ administration
The LFQ questions were worded identically on all versions. Trained
interviewers at both qualitative research firms presented the paper-,
Web-, IVRS-, and interviewer-based versions of the LFQ to partici-
pants. The paper-based version of the LFQwas self-administered by
participants in private, and the Web-based version was self-admin-
istered in private via computer. The paper- andWeb-based versions
were visually identical. After logging participants into the phone sys-
tem, the trained interviewers gave participants privacy to complete
the IVRS-based version over the telephone. During the interviewer-
based version administration, the trained interviewers read the LFQ
questions, verbatim, aloud to the participants and presented the
itemresponseoptions on cards. Participantswerenot shownwritten
versions of the questions during the IVRS-based or interviewer-
based version administrations. Interviewers did not aid participants
in responding to the questions.
Comparability evaluation
Level of modification
According to Coons et al. [4], the adaptations from the original
paper version to the Web platform are considered minor, be-
cause they were both self-administered and had identical
items, and the platform change should not have a substantive
effect on LFQ measurement properties. However, modifications
from the paper-based version to the interviewer- and IVRS-
based versions are considered moderate because different cog-
nitive processes are required from the paper-based version (i.e.,
visual vs. auditory).
Guideline for evaluation
The steps recommended for assessing comparability for minor to
moderate levels of modification under crossover designs are briefly
outlined in Figure 3 and are described in more detail in this section.
lthough all the steps in the guideline are described, the steps most
elevant for the LFQ are illustrated in greater detail.
Step 1. Item-level evaluations. Response frequency distributions
for all LFQ items for each of the six sequence groups (i.e., paper–
Web, paper–IVRS, paper–interviewer, Web–paper, IVRS–paper,
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istration, (i.e., the six sequence groups are combined over se-
quence to create three pair groups: paper/Web, paper/IVRS, paper/
interviewer) were examined to identify any potential response
anomalies, such as floor and ceiling effects or a restricted range.
Item-level descriptive statistics (e.g., mean, standard deviation,
median, and missingness) were also computed for all LFQ items
for each of the six sequence groups and the three pairs of LFQ
versions.
Item-level agreement between the paper-based and each of the
three alternate LFQ versions was assessed separately for each LFQ
item using a weighted kappa [10]. Kappas were computed by the
six sequence groups and for the three pair groups (combined over
sequence). According to Landis and Koch [11], a kappa ranging
from 0.21 to 0.41 is considered poor to fair, 0.41 to 0.60 ismoderate,
Fig. 3 – Recommended steps for assessment of
comparability between alternate questionnaire versions.0.61 to 0.80 is substantial, and over 0.81 is nearly perfect.Step 2. Total score evaluations. Total score agreement was eval-
uated based on descriptive comparisons across paper–Web, Web–
paper, paper–IVRS, IVRS–paper, paper–interviewer, and interviewer–
paper sequence groups. For measures reflecting a single underlying
construct, the internal consistency reliability should be evaluated
by computing Cronbach’s coefficient alpha [12] using item-level
data and compared across versions. Because the LFQ is a cumula-
tive risk index, items are not expected to be highly correlated;
therefore, evaluating the internal consistency reliability is not as
appropriate for the comparison across versions. For example, of
the LFQ items, clearly, the age of a participant could increase the
risk of airway obstruction, but not necessarily be strongly related
to coughing upmucus, noisiness of chest, and shortness of breath
upon physical activity.
To test for sequence effects (i.e., order or carryover effect), the
difference between the total LFQ scores for each administration
was computed. A t test was performed to compare the mean dif-
erence of LFQ scores by the sequence (e.g., paper–Web vs. Web–
aper). For example, the difference between the first and second
dministrations for participants completing the paper- and Web-
ased versionswas computed; themean difference for those com-
leting the paper–Web sequence was compared with those who
ompleted the W-P sequence. If there was no statistical evidence
or sequence effects at P  0.05, then the groups were combined,
yielding three separate analyses for each of the LFQ combined pair
groups (i.e., paper/Web, paper/IVRS, and paper/interviewer). If the
sequence effect was statistically significant, further analyses were
conducted separately for those pairs where possible.
Separate plots of the paper-based LFQ total score distributions
versus score distributions for the Web-based, IVRS-based, and in-
terviewer-based versions (combined over the sequence when the
sequence effect was nonsignificant) were examined.
Following a nonsignificant sequence effect, paired t tests pro-
vided further evidence that the score distributions between two
measures were similar, using a P value 0.05 as evidence that the
difference in the means are statistically different from zero. Fur-
thermore, the concordance between the paper-based version and
the threealternate LFQversionswasmeasuredbycomputing the ICC
using a one-way random effects analysis of variance. Separate ICC
estimates were computed for each combined pair group (i.e., paper/
Web, paper/IVRS, paper/interviewer) and compared with previous
GlaxoSmithKline estimates of the test–retest reliability for thepaper-
based version of the LFQ [13]. It is recommended that ICCs be at least
0.70 for multi-item scales, unless the purpose is to make individual
comparisons. Tomake individual comparison, a threshold of 0.85 to
0.90 is recommended [14]. Tukeymean-difference plots (also known
as the Bland-Altman plots [15]) displayed the difference between
scores versus the average of the mean scores to visually aid in as-
sessing the comparability between the LFQ versions.
Step 3. Classification evaluations. For measures that include
lassifications based on score, an evaluation should be conducted
o compare the classification agreement between themultiple ver-
ions. For the LFQ example, a score of 18 was used as the cut point,
ndicating a greater risk of airway obstruction. This cut score was
pplied to the scores on both the paper-based and the alternate
ersion and the percent agreement in classification (i.e., likely ob-
tructed vs. not likely obstructed) was computed. Additionally, the
appa statistic was computed as a measure of agreement [10].
Step 4. Usability evaluation. As another piece of the comparison,
direct feedback from participants related to completing an instru-
ment can provide important insights into how well the multiple
versions will perform in future applications. As part of the LFQ eval-
uation, eachparticipantwas asked toprovide feedbackon thepaper-
based version of the LFQ as well as the alternate version they
completed. Questions assessed any difficulty experienced when
716 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 7 1 2 – 7 2 0completing the questionnaire, ranging from 0 (not at all) to 10 (ex-
tremely), and a rating of their overall experiencewith completing the
questionnaire, ranging from 0 (terrible) to 10 (excellent).
Results
A total of 149 participants were enrolled in the study, with 135
included in the comparison. Of the 14 participants not included, 2
were excluded because they did not complete two LFQ versions
and 12 participants were omitted because they reported active
colds or infections at only one assessment, indicating a change in
their respiratory state.
The characteristics of participants assigned to theWeb-, IVRS-,
or interviewer-based versions were comparable across all charac-
teristics. The majority of the participants in this study were white
(81.0%), between the ages of 40 to 50 years (46.3%), and had at least
some college experience (bachelor’s degree 29.3%). Themajority of
participants reported having a home computer (95.2%) and Inter-
net access (93.2%). In addition, more than 80% of participants re-
Table 1 – Item-level response frequency (%) distribution an
items, by combined pair group.
LFQ item Pair Version
1. How often do you cough up mucus?
1 Paper
Web
2 Paper
IVRS
3 Paper
Interviewer
2. How often does your chest sound noisy
when you breathe? 1 Paper 1
Web 1
2 Paper 1
IVRS 1
3 Paper 1
Interviewer 1
3. How often do you experience shortness
of breath during physical activity? 1 Paper 1
Web
2 Paper 1
IVRS
3 Paper
Interviewer
4. How many years have you smoked? Nev
1 Paper
Web
2 Paper
IVRS
3 Paper
Interviewer
5. What is your age?
1 Paper
Web
2 Paper
IVRS
3 Paper
Interviewer
Note: Modal responses are bold.
IVRS, interactive voice response system; SD, standard deviation.ported either understanding most of their computer’s softwareand having little trouble learning new software or completely un-
derstanding software.
Item-level results
To identify any potential response anomalies, such as floor and
ceiling effects or a restricted scale range, item-level response fre-
quency distributions were tabulated for each of the LFQ items.
Table 1 displays the item-level response frequencies for the paper/
Web, Paper/IVRS, paper/interviewer combined pair groups. (Al-
though examined, response frequency distributions and descrip-
tive statistics for paper–Web, Web–paper, paper–IVRS, IVRS–
paper, paper–interviewer, and interviewer–paper sequence
groups are not presented.) Ceiling effects occur when the re-
sponses that occur most often (i.e., modal responses), shown
bolded and highlighted in Table 1, are in the highest category (i.e.,
a five). Ceiling effects prevent the scale from detecting further
improvements. Similarly, floor effects occur when the modal re-
sponse is in the lowest category, leaving little room to detect fur-
ther declines. As seen by the pattern of highlighted modal re-
mmary statistics for Lung Function Questionnaire (LFQ)
Response option, mean (SD) Mean (SD)
4 3 2 1
r Rarely Sometimes Often Very often
.6) 26 (54.2) 13 (27.1) 2 (4.2) 0 (0.0) 3.8 (0.7)
.7) 26 (54.2) 12 (25.0) 2 (4.2) 0 (0.0) 3.8 (0.8)
.8) 16 (35.6) 19 (42.2) 2 (4.4) 0 (0.0) 3.7 (0.8)
.0) 25 (55.6) 9 (20.0) 1 (2.2) 1 (2.2) 3.9 (0.8)
.3) 14 (33.3) 17 (40.5) 5 (11.9) 0 (0.0) 3.5 (0.9)
.3) 11 (26.2) 19 (45.2) 6 (14.3) 0 (0.0) 3.4 (0.9)
r Rarely Sometimes Often Very often
.3) 24 (50.0) 7 (14.6) 2 (4.2) 0 (0.0) 4.1 (0.8)
.4) 19 (39.6) 11 (22.9) 1 (2.1) 0 (0.0) 4.1 (0.8)
.3) 22 (48.9) 5 (11.1) 3 (6.7) 0 (0.0) 4.1 (0.8)
.2) 17 (37.8) 6 (13.3) 2 (4.4) 1 (2.2) 4.1 (1)
.8) 18 (42.9) 12 (28.6) 1 (2.4) 1 (2.4) 3.8 (0.9)
.0) 15 (35.7) 13 (31.0) 0 (0.0) 1 (2.4) 3.9 (0.9)
r Rarely Sometimes Often Very often
.9) 13 (27.1) 20 (41.7) 4 (8.3) 0 (0.0) 3.6 (0.9)
.7) 15 (31.3) 20 (41.7) 5 (10.4) 0 (0.0) 3.5 (0.9)
.2) 19 (42.2) 12 (26.7) 4 (8.9) 0 (0.0) 3.8 (0.9)
.3) 19 (42.2) 17 (37.8) 2 (4.4) 1 (2.2) 3.6 (0.9)
) 12 (28.6) 16 (38.1) 8 (19.0) 3 (7.1) 3.1 (1.0)
) 14 (33.3) 17 (40.5) 5 (11.9) 3 (7.1) 3.2 (1.0)
oked  10 y 11–20 y 21–30 y  30 y
) 7 (14.6) 11 (22.9) 18 (37.5) 12 (25.0) 2.3 (1.0)
) 6 (12.5) 10 (20.8) 19 (39.6) 13 (27.1) 2.2 (1.0)
) 5 (11.1) 13 (28.9) 16 (35.6) 10 (22.2) 2.4 (1.0)
) 4 (8.9) 16 (35.6) 12 (26.7) 11 (24.4) 2.4 (1.1)
) 3 (7.1) 13 (31.0) 16 (38.1) 10 (23.8) 2.2 (0.9)
) 2 (4.8) 11 (26.2) 17 (40.5) 12 (28.6) 2.1 (0.9)
y 40–49 y 50–59 y 60–69 y 70 y
) 23 (47.9) 11 (22.9) 10 (20.8) 3 (6.3) 3.2 (1)
) 24 (50.0) 11 (22.9) 10 (20.8) 3 (6.3) 3.2 (1)
) 15 (33.3) 19 (42.2) 6 (13.3) 3 (6.7) 3.2 (1)
) 17 (37.8) 19 (42.2) 6 (13.3) 3 (6.7) 3.1 (0.9)
) 15 (35.7) 13 (31.0) 11 (26.2) 2 (4.8) 3.0 (1)
) 16 (38.1) 13 (31.0) 11 (26.2) 2 (4.8) 3.0 (0.9)d su
5
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0 (0.0sponses for the LFQ, there are no ceiling or floor effects.
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Web, paper/IVRS, and paper/interviewer) was typically either
identical or separated by only one category. This finding indicates
that, in general, participants responded similarly at the two ad-
ministrations. For example, for Item 1 (cough up mucus) paper-
andWeb-based versions both havemodal responses in Category 4,
with 54.2% of participants responding.
Another relevant response anomaly occurswhen response cat-
egories are never or rarely endorsed, indicating a restricted re-
sponse scale range. The majority of participants responded
“Never” (Response Category 5) “Rarely” (Response Category 4), or
“Sometimes” (Response Category 3) on Items 1, 2, and 3. In fact, few
participants reported experiencing these symptoms “Often” (i.e., Re-
sponseCategory 4), ranging from less than14.3%on Item1 (coughing
upmucus), less than 7% on Item 2 (noisy chest), and fewer than 19%
on Item 3 (shortness of breath during physical activity). Notably,
fewer than three participants per version reported “Very often” (Re-
sponse Category 1) experiencing the symptoms described by Item 1
(coughing up mucus), Item 2 (noisy chest), and Item 3 (shortness of
breath during physical activity). Table 1 provides the mean item re-
sponse and its standard deviation by version. It is apparent that the
versions have similar magnitude of item-level means, with slightly
lower means for participants assigned to the interviewer-based ver-
sion, indicating that those participants reported slightly more fre-
quent symptoms of obstruction.
Table 2 contains the kappa statistic estimates and correspond-
ing 95% confidence intervals as measures of agreement between
LFQ item-level responses of the paper-based and alternate ver-
sions for the six sequence groups. (Although examined, kappa sta-
tistics for the combined pair groups, paper/Web, paper/IVRS, and
paper/interviewer, are not presented.) The kappa statistics are
highly satisfactory, with the lowest observed at 0.52 for Item 3
(“Howoften do you experience shortness of breath during physical
activity?”) between IVRS-P sequence and the highest estimated for
Item 5 (“What is your age?”) for all six sequences (range 0.97–1.00).
Table 2 – Lung Function Questionnaire (LFQ) item-level kap
LFQ item
Paper–web Web–paper Paper–IV
1 0.90 (0.80, 1.00) 0.78 (0.56, 0.99) 0.73 (0.51, 0
2 0.83 (0.70, 0.96) 0.76 (0.56, 0.96) 0.79 (0.63, 0
3 0.84 (0.71, 0.96) 0.67 (0.48, 0.85) 0.72 (0.53, 0
4 0.91 (0.83, 0.99) 0.97 (0.92, 1.00) 0.90 (0.81, 0
5 0.98 (0.95, 1.00) 1.00 (1.00, 1.00) 1.00 (1.00, 1
CI, confidence interval; IVRS, interactive voice response system.
Table 3 – Lung Function Questionnaire (LFQ) total score de
Sequence Version n M
Paper–Web Paper 25 1
Web 25 1
Web–Paper Paper 23 1
Web 23 1
Paper–IVRS Paper 23 1
IVRS 23 1
IVRS–Paper Paper 22 1
IVRS 22 1
Paper–Interview Paper 22 1
Interviewer 22 1
Interview–Paper Paper 20 1
Interviewer 20 1IVRS, interactive voice response system; SD, standard deviation.Total score results
The descriptive statistics for the LFQ total scores for the six se-
quence groups are displayed in Table 3. (Although examined, total
scores for the combined pair groups, paper/Web, paper/IVRS, and
paper/interviewer, are not presented.) The scores ranged from a
minimum of 8.0 to a maximum of 23.0. The means and medians
for all combined pair groups were less than 18 points, the cutpoint
used in previous studies for indicating a greater risk of obstruc-
tion. Notably, the standard deviationswere comparable across the
combined pair groups, ranging from a low of 2.0 to a high of 2.9.
Participants given the paper–interviewer and interviewer–paper
sequences had the lowest LFQ means, and the largest score
spread; participants assigned to the paper–Web and Web–paper
sequences had comparable means; and participants given the pa-
per–IVRS and IVRS–paper sequences had the highest.
Before comparing the LFQ version scores and classifications,
we tested to see if a statistically significant sequence effect was
observed. This effect is important to consider because it would be
unacceptable if a participant’s responses were dependent on
which mode was received first. To test this effect, we computed
the differences for each participant between the first and second
administrations and using a t test, compared those who received
the paper-based version first to those who received the paper-
based version at the final administration. Table 4 shows themeans
for the paper-based version and the alternate version, and the
difference between the two versions. For example, the first row in
Table 4 compares the sequence groups paper–Web andWeb–paper.
In the paper–W sequence group, the mean of both the paper- and
Web-based versions was 16.8, indicating no difference between the
two versions, on average. In the Web–paper group, the paper-based
mean was 17.1, and the Web-based mean was 16.8; again, a very
small difference, on average, of 0.3. The t test was computed to de-
termine if thedifference of 0.3 observedbetween thepaper–Weband
tatistics, by sequence group.
pa (95% CI)
IVRS–paper Paper–interview Interview–paper
0.60 (0.32, 0.88) 0.72 (0.44, 1.00) 0.84 (0.63, 1.00)
0.78 (0.59, 0.96) 0.73 (0.55, 0.92) 0.88 (0.73, 1.00)
0.52 (0.16, 0.89) 0.67 (0.45, 0.88) 0.79 (0.58, 0.99)
0.85 (0.70, 1.00) 0.83 (0.67, 0.99) 0.85 (0.64, 1.00)
0.97 (0.92, 1.00) 0.97 (0.92, 1.00) 1.00 (1.00, 1.00)
tive statistics by sequence group.
SD Median Min Max
2.7 17.0 10.0 22.0
2.4 17.0 11.0 21.0
2.0 17.0 13.0 20.0
2.0 17.0 13.0 20.0
2.2 17.0 12.0 22.0
2.4 17.0 14.0 22.0
2.8 17.0 13.0 23.0
2.9 17.5 12.0 22.0
2.7 15.0 11.0 20.0
2.4 15.0 11.0 20.0
2.9 16.0 8.0 20.0
2.9 15.0 8.0 20.0pa s
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718 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 7 1 2 – 7 2 0Web–paper sequence was statistically significant. The resulting T
value of 1.1 was nonsignificant with a P value of 0.27.
No significant differences between the paper-based version
nd the alternate versions were found, irrespective of the order of
dministration [i.e., paper–Web, paper-IVRS, paper–interviewer,
eb–paper, IVRS–paper, and interviewer–paper]). Hence, all fur-
her analyses were combined over sequence, yielding three sepa-
ate analyses, one for each combined pair group (i.e., paper/Web,
aper/IVRS, paper/interviewer).
To visually demonstrate the relationship between the LFQ total
cores and version, six box plots—a pair of box plots for each of the
ombined pair groups—are displayed in Figure 4. Each box plot
epresents the distribution of LFQ total scores, with the lower and
pper edges of the box denoting the 25th and 75th percentiles,
espectively. The horizontal linewithin the box is the 50th percen-
ile (i.e., median) of the score distribution. The “whiskers” on each
ox show the range of score values and visually depict the vari-
bility of each distribution of scores. The gray line connects the
eans across the boxes.
Looking across Figure 4, the first pair of pink boxes shows the
ange of scores for the paper/interviewer combined pair, the sec-
nd pair of blue boxes represents the paper/IVRS combined pair,
nd the last pair of yellow boxes is the distribution of scores for the
aper/Web combined pair. In general, the means and spread of
ach pair of boxes are highly comparable. Somewhat more vari-
bility and negative skewness can be observed in the scores of the
aper/interviewer combined pair (pink boxes). The maximum
core, however, for the paper/interviewer combined pair was ap-
roximately 20, indicating that these participants are more likely
o be at risk for airway obstruction based on the LFQ.
Paired t testswere conducted to investigatewhether the LFQ ver-
sions were highly comparable at the total LFQ score level. Specifi-
cally, the difference in the mean scores between the paper-based
Fig. 4 – Comparison of LFQ total score distributions across
Table 4 – Sequence effect test.
Alternate
version
Paper-based version administered firs
Paper
mean
(SD)
Alternate
mean
(SD)
Difference between
paper and
alternate mean (SD)
Web 16.8 (2.7) 16.8 (2.4) 0.0 (1.0)
IVRS 17.0 (2.2) 17.4 (2.4) –0.5 (1.3)
Interviewer 15.4 (2.7) 15.7 (2.4) –0.3 (1.0)
IVRS, interactive voice response system; SD, standard deviation.versions.version and the alternate version for each of the three combined pair
groups was computed and a paired t test was performed (i.e., where
the null hypothesis is zero). A P value  0.05 was taken as evidence
that the difference in themeanswas statistically different fromzero.
The mean difference between the paper-based and Web-based ver-
sion scores in the paper/Web combined pairwas 0.2 (SD 0.8), yield-
ing a nonsignificant t statistic of 1.4. For the paper/IVRS scores, the
mean difference was 0.1 (SD  1.6) and the t statistic was nonsig-
nificant at 0.5. The paper/interviewer mean difference was also
close to small at 0.1 (SD 1.3) and nonsignificant. These results pro-
vide evidence that the difference in the LFQ version means was not
statistically different from zero.
In addition to the t tests, ICCs for the LFQ total scores between the
paper-based version and each alternate versionwere computed and
are provided in Table 5. The ICCs are exceptionally higher than the
threshold of 0.70, ranging from 0.81 to 0.93. Notably, the minimum
point on the 95% confidence interval is very close to 0.70 for paper/
IVRS, while the maximum is near or above 0.90. This provides evi-
dence that the LFQ total scoreswere stable across the 7daysbetween
assessments, andmore importantly, that the paper-based and alter-
nate versions show exceptionally good agreement.
As an aid in assessing the comparability between the LFQ ver-
sions, Tukey mean-difference plots are presented in Figure 5.
These plots can help one visually determine whether or not any
two measures are producing the same scores, and support the
evidence gained from the ICC evaluation. In each figure, the with-
in-subject difference in LFQ scores (i.e., between the paper and
alternate versions) is plotted against the average of the LFQ ver-
sion scores (i.e., the paper and alternate versions). For versions to
be comparable, the difference between versions should remain
constant, with points preferably close to zero across the entire
range of mean scores. Bias occurs when one version is always
higher than another and can be seen when the points on the plot
are either consistently below or above the zero-difference line.
The size of the circle plotted and corresponding number shown in
each figure indicates the number of participantswhohad identical
difference and mean scores. For example, the first panel in Figure
5 shows that the average paper/Web combined pair score for 6
participants was 17 and the difference between versions was 0.
Therefore, the LFQ scores were 17 for both the paper/Web admin-
Paper-based version
administered last
Test of
sequence
difference
er
an
D)
Alternate
mean
(SD)
Difference between
paper and
alternate mean (SD)
t test P value
(2.0) 16.8 (2.0) 0.3 (0.6) 1.1 0.27
(2.8) 16.9 (2.9) 0.3 (1.8) 1.6 0.11
(2.9) 15.6 (2.9) 0.5 (1.5) 1.9 0.07
Table 5 – Intraclass correlation coefficients (ICC)
between paper-based and the alternate version, by
combined pair group.
Paper-based with alternate version ICC (95% CI)
Web 0.93 (0.88–0.96)
IVRS 0.81 (0.68–0.89)
Interviewer 0.88 (0.79–0.93)t
Pap
me
(S
17.1
17.1
16.1CI, confidence interval; IVRS, interactive voice response system.
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719V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 7 1 2 – 7 2 0istrations (i.e., excellent agreement). As seen in the first panel of
Figure 4, across the range of average scores, the within-subject
differences between the paper/Web is low (i.e., between a zero and
one-point difference), with only three participants having larger
differences. Two out of the three participants had higher scores on
the paper-based version (i.e., circles above the middle line) and
one participant had higher scores on the Web-based version.
The range of means was approximately 10 to 22. Whenever
there is a relatively higher range of mean scores (between-sub-
jects variability) compared with a relatively low range of differ-
ence scores (within-subjects variability), this difference should
correspond to a high ICC. In fact, the ICC for the paper/Web
combined pair is quite high at 0.93. Furthermore, the greatest
difference between the paper/Web LFQ scores of three occurred
in the range of 16 to 17, very close to the cutpoint of 18, leading
to the situation where a participant might be classified as at risk
using theWeb-based version (lower score) and not at risk by the
paper-based version (higher score). The second panel in Figure 5
provides the plots for the paper/IVRS comparison and third
panel of Figure 5 provides the plot for the paper/interviewer
omparison. As shown in the second panel of Figure 5, the range
f mean scores is relatively high but not as high compared with
he range of differences for the within-subject differences yield-
Fig. 5 – Tukey mean-difference plots by version pairs.ng an ICC of 0.81. Finally, the third panel of Figure 5 shows that,gain, the majority of the circles on the plot are close to the
iddle line indicating comparable scores. The range of means
or this pair of administration versions is still broader than the
ithin-subject differences, suggesting a high ICC. Indeed, the
CC was 0.88.
Classification results
For this study, a score of 18 was considered the cutpoint, indi-
cating a greater risk of airway obstruction. This cutpoint was
applied to the LFQ scores on both the paper-based and the al-
ternate administration versions. Table 6 shows the percent
agreement in classification (i.e., likely obstructed vs. not likely
obstructed).
Overall, the classifications were highly comparable across
versions (Table 6). For the paper/Web combined pair compari-
sons, approximately 71% (n  34) of the sample was considered
at risk of airway obstruction and 25% (n  12) were considered
not at risk by both versions. Only two participants were classi-
fied as having airway obstruction risk using the Web-based ver-
sion but were classified as not at risk for obstruction with the
paper-based version. The kappa statistic—indicating classifica-
tion agreement—was highly satisfactory at 0.89. The paper/
IVRS combined pair classified 62.2% (n  28) participants as
having a higher risk of airway obstruction and 12 (26.7%) partic-
ipants as not at risk, yielding a high overall agreement of ap-
proximately 89%. Notably, the only disagreement in classifica-
tion between versions occurred for five participants (11.1%) who
were classified as being at risk using the paper-based version,
but not by the IVRS-based version. Still, the kappa statistic of
0.75 indicates good agreement. The paper/interviewer com-
bined pair resulted in the lowest kappa of 0.54, but had a very
high percentage of overall agreement at 85.7%. A majority of
participants (73.8%) were classified as at risk or not at risk
(11.9%) by both the paper- and interviewer-based versions.
However, six participants were classified differently. Because
the computation of the kappa statistic is dependent on the base
rate, it is likely that the kappa statistic is lower in this version
pair because of the small numbers of participants having LFQ
scores  18 points (n  5) (see Table 6).
Given the Landis and Koch guidelines [6] for assessing the
magnitude of kappa, the agreement in classification is nearly
perfect for the paper/Web combined pair, substantial for the
paper/IVRS combined pair, and moderate for the paper/inter-
viewer combined pair.
Usability and administration version preference results
The IVRS version appeared to be slightly more difficult to com-
plete. More than 95% of participants reported no difficulties at
all completing the paper-based, interviewer-based or Web-
based versions, whereas 87% reported no difficulties completing
the IVRS-based version. The remaining 13% assigned to the IVRS
version reported just “slight” difficulty. Upon questioning, the
most commonly reported complaint was that the IVRS system
required respondents to wait until all answer choices were
given for each question before the system would allow the se-
lection of a response. When asked about their overall experi-
ence completing the questionnaire, approximately 98% of par-
ticipants reported having a good to excellent experience using
the paper- and Web-based, 96% reported good to excellent for
the interviewer-based and 90% for the IVRS-based.
Conclusions
Including PROs within studies can provide insights into disease
burden and treatment efficacy. In fact, when there is no biolog-
ical measure or it is difficult to obtain, PROs are key in assessing
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720 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 7 1 2 – 7 2 0disease improvement. Offering multiple versions for collecting
PRO data, or multiple methods for collecting data, could in-
crease the acceptance and accessibility of PRO instruments, as
long as the instrument versions do not differ in complexity of
responder privacy (or perceived privacy). Although, providing
additional versions has advantages, there are few resources
that describe how to evaluate the comparability of data when a
PRO has been collected usingmultiple versions. This article out-
lines recommended steps for comparing alternative versions in
a crossover study that have undergone minor to moderate mod-
ifications as described by Coons et al. [4] to evaluate if additional
measurement error has been introduced or if the data collected
through the versions can be combined and analyzed. An exam-
ple using the LFQ, a case-finding tool originally designed for
paper administration and adapted for three alternative versions
using Internet, interview administration, and telephone tech-
nology, provides a step-by-step illustration of the evaluation
guide. In our example, the results are positive. The item-level
responses were very similar between the three combined pair
groups and the total score means were highly comparable. A
test of sequence effect was nonsignificant, indicating that the
order of administration did not affect a participant’s score on
the LFQ. Hence, further analyses comparing ICCs and mean dif-
ferences were combined across sequence. Statistical tests of the
differences in the LFQ scores and concordance results con-
firmed the comparability of the total scores. The ICCs were large
( 0.70) for the paper/Web and paper/interviewer combined pair
roups indicating that the responses on the paper-based ver-
ion were highly comparable to those of the Web-based and
nterviewer-based versions. The paper/IVRS combined pair
oint estimate was slightly lower at 0.81 and had a wider 95%
onfidence interval that just incorporated 0.70. The Tukey
ean-difference plots provided a visual evaluation. Further-
ore, there was moderate to near-perfect agreement according
o the item-level kappa statistics for the classifications based on
he total scores.
There are several limitations to this study. Because the LFQ
was developed as a case-finding tool, we based our ICC thresh-
olds at 0.70 and not a higher bar of 0.90 (a threshold used to
compare one individual’s score with another individual’s
score). Using the 0.90 threshold, only the paper/Web adminis-
tration would have an acceptable ICC. In addition, this study did
not include spirometry, the gold standard for determining true
airway obstruction risk; hence, new candidate cut points across
versions could not be estimated or compared. Further psycho-
metric evaluation within each version of the LFQ could help
investigate and understand the lower ICC observed in the pa-
per/IVRS combined pair group, and the higher rate of disagree-
ment (14%) in the paper/interviewer combined pair group.
Taken together, the evidence indicated high comparability
between the item-level responses and the total scores of the
LFQ, regardless of administration version. As a final evaluation,
Table 6 – Percent agreement in obstruction risk between p
group.
Paper-based with
alternate version
Obstruction risk
both versions
n (%)
No obstruction
risk both
versions n (%)
Web 34 (70.8) 12 (25.0)
IVRS 28 (62.2) 12 (26.7)
Interviewer 31 (73.8) 5 (11.9)
IVRS, interactive voice response system.participants’ preferences also indicated that, although partici-pants had a preference, they reported few difficulties with the
versions they were assigned.
The steps described here provide a guide for evaluating
whether or not to combine scores across multiple administra-
tion versions in a crossover study. This guide recommends the
investigation of item responses, summary scores, and partici-
pant usability/preference when comparing versions, with each
step providing unique information to support a comprehensive
evaluation and informed decisions regarding whether or not to
combine data across versions.
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